Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Irama, Villar"'
Autor:
Eguzkine Ochoa, Mikel Iriondo, Carmen Manzano, Asier Fullaondo, Irama Villar, Guillermo Ruiz-Irastorza, Ana M Zubiaga, Andone Estonba
Publikováno v:
PLoS ONE, Vol 11, Iss 1, p e0146990 (2016)
The identification of the genetic risk factors that could discriminate non- thrombotic from thrombotic antiphospholipid antibodies (aPLA) carriers will improve prognosis of these patients. Several human studies have shown the presence of aPLAs associ
Externí odkaz:
https://doaj.org/article/896de7fc4dd8410d948139cf0dfe9c75
Autor:
Jose-Gabriel, Erdozain, Jose-Ignacio, Pijoan, Irama, Villar, Javier, Nieto, Ioana, Ruiz-Arruza, Guillermo, Ruiz-Irastorza, Agustin, Martinez-Berriotxoa
Publikováno v:
Clinical and experimental rheumatology. 38(5)
To determine the potential predictive value in patients with systemic lupus erythematous of the ankle-brachial index (ABI) for the occurrence of arterial vascular events.216 lupus patients from a prospective clinical cohort were evaluated using the A
Autor:
Guillermo Ruiz-Irastorza, Ioana Ruiz-Arruza, J-I Pijoan, Irama Villar, Javier Nieto, J-G Erdozain
Publikováno v:
Poster Presentations.
Background Arterial vascular events (AVE) are among the major causes of morbidity and mortality in patients with Systemic Lupus Erythematosus (SLE). Several studies have been carried out to identify the main factors related to AVE in this population.
Autor:
Javier Nieto, Guillermo Ruiz-Irastorza, Irama Villar, Ioana Ruiz-Arruza, Jose Gabriel Erdozain
Publikováno v:
Lupus Science & Medicine
Addi. Archivo Digital para la Docencia y la Investigación
instname
Addi. Archivo Digital para la Docencia y la Investigación
instname
OBJECTIVE: To analyse the differential influence of risk factors of peripheral artery disease (PAD) according to age in patients with SLE. METHODS: 216 patients from the Lupus-Cruces cohort were divided in three age groups: ≤34 years, 35-49 years a
Autor:
Ãlvaro Danza, Isabel Perales, Sonia Delgado, Guillermo Ruiz-Irastorza, Irama Villar, Munther A. Khamashta, Miriam Ureta García
Publikováno v:
Autoimmunity Reviews. 13:206-214
To assess the effectiveness and safety of a protocol using medium doses of prednisone to treat lupus nephritis.Patients receiving the 'Cruces-protocol cohort' (CPC) were paired 1:2 with patients from the 'historic cohort' (HC). The CPC received mediu
Autor:
Guillermo Ruiz-Irastorza, Maider Garmendia, Irama Villar, Ciriaco Aguirre, Maria-Victoria Egurbide
Publikováno v:
Autoimmunity Reviews. 12:410-415
Objectives To investigate the prevalence and predictors of pulmonary hypertension (PH) in patients with systemic lupus erythematosus (SLE) and to validate a diagnostic strategy. Methods 245 patients with SLE entered a screening program. Possible PH w
Autor:
Irama Villar, Mikel Iriondo, C. Manzano, Guillermo Ruiz-Irastorza, Ana M. Zubiaga, Andone Estonba, Eguzkine Ochoa, Asier Fullaondo
Publikováno v:
PLoS ONE, Vol 11, Iss 1, p e0146990 (2016)
PLoS ONE
Addi. Archivo Digital para la Docencia y la Investigación
instname
PLoS ONE
Addi. Archivo Digital para la Docencia y la Investigación
instname
Introduction The identification of the genetic risk factors that could discriminate non-thrombotic from thrombotic antiphospholipid antibodies (aPLA) carriers will improve prognosis of these patients. Several human studies have shown the presence of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::909aae7dd8b55e0c1cfcb7adf78754d7
http://hdl.handle.net/10810/18224
http://hdl.handle.net/10810/18224
Autor:
Guillermo Ruiz-Irastorza, Irama Villar
Publikováno v:
Seminarios de la Fundación Española de Reumatología. 7:59-69
The antiphospholipid syndrome (APS) is a well known cause of pregnancy complications, including maternal thrombosis and preeclampsia as well as embryofetal losses. A multidisciplinary, medical-obstetric approach is of great importance in the clinical
Publikováno v:
JCR: Journal of Clinical Rheumatology. 11:129-133
Dosing of allopurinol should be corrected depending on renal function, but corrections based on either plasma creatinine (Pcr) or creatinine clearance (CrCl) have been suggested to be minimal standards of care.Data from a cohort database of 484 gouty
Publikováno v:
The Journal of rheumatology. 41(2)
Objective.To analyze the prevalence of peripheral arterial disease (PAD) and cardiovascular (CV) risk factors in a cohort of patients with systemic lupus erythematosus (SLE) and to identify variables potentially related to PAD.Methods.The study inclu